Correction: Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long- term extension study

Correction: Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long- term extension study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-01-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/1/e004476corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
by: Hendrik Schulze-Koops, et al.
Published: (2024-10-01)

The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
by: Yoshiya Tanaka, et al.
Published: (2024-11-01)

Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study).
by: Mitsuhiro Akiyama, et al.
Published: (2025-01-01)

Long-term results of elbow synovectomy and debridement in rheumatoid arthritis
by: Anastasia Aleksandrovna Roskidailo, et al.
Published: (2011-12-01)

Baricitinib: key results of long-term use in rheumatoid arthritis
by: N. V. Chichasova, et al.
Published: (2024-08-01)

Long‐Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER‐OLE Study
by: Ahmad Masri, et al.
Published: (2024-04-01)

Correction: Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis
Published: (2024-11-01)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study
by: Valentina Yu. Myachikova, et al.
Published: (2024-10-01)

Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
by: Tsutomu Takeuchi, et al.
Published: (2025-03-01)

STRATEGY OF LONG-TERM DEVELOPMENT OF RUSSIAN PENSION SYSTEM: ANALYSIS OF INTERIM RESULTS
by: Pavel A. Kozlov
Published: (2017-09-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
by: N. V. Chichasova
Published: (2016-06-01)

Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
by: Tilmann Kallinich, et al.
Published: (2024-02-01)

Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension study
by: Joan T Merrill, et al.
Published: (2025-08-01)

Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis
by: Yoshiya Tanaka, et al.
Published: (2025-04-01)

Basic trends and variability of rheumatoid arthritis evolution: long-term follow-up results
by: D. E. Karateev
Published: (2004-02-01)

Retrospective investigation of the results of long-term treatment with disease modifying drugs in rheumatoid arthritis
by: D Karateev
Published: (2003-06-01)

DISEASE MODIFYING THERAPY AND OUTCOME OF RHEUMATOID ARTHRITIS: RETROSPECTIVE ASSESSMENT OF LONG-TERM RESULTS
by: D. E. Karateyev, et al.
Published: (2000-02-01)

TECHNOSPHERE SAFETY IN THE ARCTIC: INTERIM RESULTS AND DEVELOPMENT PATHS
by: Irina F. Zenkova
Published: (2025-06-01)

Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
by: Prasad T. Oommen, et al.
Published: (2024-12-01)

A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
by: R. M. Balabanova
Published: (2018-12-01)

In which patients with ulcerative colitis would filgotinib be effective?
by: Jihye Park
Published: (2025-01-01)

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
by: Gerd R Burmester, et al.
Published: (2019-10-01)

MEDIUM-TERM RESULTS OF TOTAL ELBOW ARTHROPLASTY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. G. Aliev, et al.
Published: (2018-11-01)

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
by: V. I. Mazurov, et al.
Published: (2023-03-01)

Impact of filgotinib on pain control in the phase 3 FINCH studies
by: Bruno Fautrel, et al.
Published: (2024-02-01)

Factors determining long-term success of biologic therapy in rheumatoid arthritis
by: Dmitry Evgenyevich Karateev
Published: (2015-09-01)

The long-term remission of rheumatoid arthritis with a single cycle of rituximab
by: Glišić Branislava, et al.
Published: (2012-01-01)

Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis
by: Marina G. Birck, et al.
Published: (2025-07-01)

Efficacy and safety of rapid dose escalation of methotrexate in rheumatoid arthritis. Results of the multicenter “METEOR” study
by: V. N. Amirjanova, et al.
Published: (2025-03-01)

Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.
by: Paul Emery, et al.
Published: (2014-01-01)

THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE
by: D. A. Kusevich, et al.
Published: (2017-09-01)

Association of Long‐Term Exposure to PM2.5 Constituents and Green Space With Arthritis and Rheumatoid Arthritis
by: Yi‐Sheng He, et al.
Published: (2024-11-01)

Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
by: V. I. Mazurov, et al.
Published: (2021-05-01)

TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2016-07-01)

P026: Interim analysis of the efficacy and safety of weekly intravenous tividenofusp alfa in mucopolysaccharidosis type II: A phase 1/2 study
by: Barbara Burton, et al.
Published: (2025-01-01)

Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study
by: Fayyaz Ahmed, et al.
Published: (2025-05-01)

Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)